Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jorge Cortes
Acute Myeloid Leukemia With T(10;11): A Pathological Entity With Distinct Clinical Presentation
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Molecular Resistance: An Early Indicator for Treatment Change?
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Loss of TRIM62 Expression Is an Independent Adverse Prognostic Factor in Acute Myeloid Leukemia
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Azacitidine in Fludarabine-Refractory Chronic Lymphocytic Leukemia: A Phase II Study
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Value of Oligonucleotide-Based Array Comparative Genomic Hybridization for Diagnosis of Acute Promyelocytic Leukemia in a Patient Negative for T(15;17)(q24.1;q21.2)/Promyelocytic Leukemia-Retinoic Acid Receptor, Alpha by Conventional Cytogenetics and Fluorescence in Situ Hybridization
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Acute Myeloid Leukemia After Myelodysplastic Syndrome and Failure of Therapy With Hypomethylating Agents: An Emerging Entity With a Poor Prognosis
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
A Phase I and Pharmacodynamic Study of AT9283, a Small-Molecule Inhibitor of Aurora Kinases in Patients With Relapsed/Refractory Leukemia or Myelofibrosis
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Biological and Clinical Features of Trisomy 21 in Adult Patients With Acute Myeloid Leukemia
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Patterns of Molecular Response to and Relapse After Combination of Sorafenib, Idarubicin, and Cytarabine in Patients With FLT3 Mutant Acute Myeloid Leukemia
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Outcomes in Patients With Relapsed or Refractory Acute Promyelocytic Leukemia Treated With or Without Autologous or Allogeneic Hematopoietic Stem Cell Transplantation
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
‹
1
2
3
4
5
6
›
